⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

October 1, 2008Expert Review of Anticancer TherapyOpen Access

Optimal approach to potentially resectable liver metastases from colorectal cancer

Alfredo Falcone Lorenzo Fornaro Fotios Loupakis Gianluca Masi Enrico Vasile

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Colorectal cancer (CRC) represents the second most frequent cause of cancer-related death in Western countries [1]. In the last decade, improvements in the management of metastatic CRC (mCRC) have ...

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Falcone et al. (2008) studied this question.

synapsesocial.com/papers/6a86b709c481b082b0cb8983 https://doi.org/10.1586/14737140.8.10.1533

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1The Continuum of Care: A Paradigm for the Management of Metastatic Colorectal CancerOriginal Research · 2007 · 238 citations
2Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trialOriginal Research · 2000 · 3,242 citations
3Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal CancerOriginal Research · 2000 · 2,992 citations
4Phase III Study of Weekly High-Dose Infusional Fluorouracil Plus Folinic Acid With or Without Irinotecan in Patients With Metastatic Colorectal Cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986Late-Phase Clinical Trial · 2005 · 330 citations
5Phase III Multicenter Randomized Trial of Oxaliplatin Added to Chronomodulated Fluorouracil–Leucovorin as First-Line Treatment of Metastatic Colorectal CancerLate-Phase Clinical Trial · 2000 · 1,393 citations
6Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal CancerCohort Study · 2000 · 3,801 citations
7Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal CancerOriginal Research · 2004 · 10,915 citations
8Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal CancerClinical Trial · 2004 · 5,042 citations
9TROP2-directed antibody-drug conjugates (ADCs) challenge of predicting clinical outcomeExpert Review of Anticancer Therapy · 2026
10Survivorship in gynecological cancers: addressing psychosocial and physical challengesExpert Review of Anticancer Therapy · 2026

More from Expert Review of Anticancer Therapy

More from University of Pisa

More from Ospedale di Livorno